Avalon Investment & Advisory Biomarin Pharmaceutical Inc Transaction History

Avalon Investment & Advisory

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$72.61 - $90.2 $408,140 - $507,014	-5,621 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$71.87 - $131.03 $79,488 - $144,919	1,106 Added 24.5%	5,621 $428,000
Q2 2020 Aug 07, 2020	BUY	$79.55 - $124.22 $359,168 - $560,853	4,515 New	4,515 $557,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.